US09077D2099 - Common Stock
BIOFRONTERA INC
NASDAQ:BFRI (4/25/2024, 4:50:51 PM)
After market: 1.77 +0.08 (+4.73%)1.69
+0.03 (+1.81%)
Biofrontera Inc is a US-based company operating in Pharmaceuticals industry. The company is headquartered in Woburn, Massachusetts and currently employs 81 full-time employees. The company went IPO on 2021-10-14. Biofrontera Inc. is a biopharmaceutical company. The firm is focused on commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. The Company’s licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. Its principal licensed product is Ameluz, which is a prescription drug for use in combination with the BF-RhodoLED lamp series, for photodynamic therapy. In the United States, the PDT treatment is used for the lesion-directed and field-directed treatment of actinic keratoses (AK) of mild-to-moderate severity on the face and scalp. The Company’s other products include Xepi for the treatment of impetigo, a common skin infection, due to Staphylococcus aureus or Streptococcus pyogenes. The company is used in the United States in adults and children two months and older.
BIOFRONTERA INC
120 Presidential Way,, Suite 330
Woburn MASSACHUSETTS
P: 17812451325
CEO: Erica Monaco
Employees: 81
Website: https://www.biofrontera-us.com/
The regular session of the US market on Friday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
If you want the chance at possible absurd returns, then consider gambling on these stocks to turn $1,000 into $1 million.
BFRI stock results show that Biofrontera beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biofrontera (NASDAQ:BFRI) just reported results for the fourth quarter of 2023....
It's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Wednesday!
Here you can normally see the latest stock twits on BFRI, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: